Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

被引：1003

作者：

Kamar, Nassim ^{[1
,2
]}

Selves, Janick ^{[3
]}

Mansuy, Jean-Michel ^{[4
]}

Ouezzani, Leila ^{[1
]}

Peron, Jean-Marie ^{[2
,5
]}

Guitard, Joelle ^{[1
]}

Cointault, Olivier ^{[1
]}

Esposito, Laure ^{[1
]}

Abravanel, Florence ^{[4
,6
]}

Danjoux, Marie ^{[3
]}

Durand, Dominique ^{[1
]}

Vinel, Jean-Pierre ^{[5
]}

Izopet, Jacques ^{[4
,6
]}

Rostaing, Lionel ^{[1
,6
]}

机构：

[1] CHU Rangueil, Dept Nephrol Dialysis & Multiorgan Transplantat, F-31059 Toulouse 9, France

[2] CHU Rangueil, INSERM, Unite 858, IFR 31, F-31059 Toulouse, France

[3] CHU Purpan, Dept Histopathol, Toulouse, France

[4] CHU Purpan, Dept Virol, Toulouse, France

[5] CHU Purpan, Dept Hepatol, Toulouse, France

[6] CHU Purpan, INSERM, Unite 563, IFR 30, Toulouse, France

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 08期

关键词：

D O I：

10.1056/NEJMoa0706992

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatitis E virus (HEV) is considered an agent responsible for acute hepatitis that does not progress to chronic hepatitis. We identified 14 cases of acute HEV infection in three patients receiving liver transplants, nine receiving kidney transplants, and two receiving kidney and pancreas transplants. All patients were positive for serum HEV RNA. Chronic hepatitis developed in eight patients, as confirmed by persistently elevated aminotransferase levels, serum HEV RNA, and histologic features of chronic hepatitis. The time from transplantation to diagnosis was significantly shorter and the total counts of lymphocytes and of CD2, CD3, and CD4 T cells were significantly lower in patients in whom chronic disease developed. Copyright © 2008 Massachusetts Medical Society.

引用

页码：811 / 817

页数：7

共 24 条

[1] INHIBITION OF HUMAN B-LYMPHOCYTE CELL-CYCLE PROGRESSION AND DIFFERENTIATION BY RAPAMYCIN [J].

AAGAARDTILLERY, KM ;

JELINEK, DF .

CELLULAR IMMUNOLOGY, 1994, 156 (02) :493-507

[2] An algorithm for the grading of activity in chronic hepatitis C [J].

Bedossa, P ;

Poynard, T .

HEPATOLOGY, 1996, 24 (02) :289-293

[3] EPIDEMIC HEPATITIS-E IN PAKISTAN - PATTERNS OF SEROLOGIC RESPONSE AND EVIDENCE THAT ANTIBODY TO HEPATITIS-E VIRUS PROTECTS AGAINST DISEASE [J].

BRYAN, JP ;

TSAREV, SA ;

IQBAL, M ;

TICEHURST, J ;

EMERSON, S ;

AHMED, A ;

DUNCAN, J ;

RAFIQUI, AR ;

MALIK, IA ;

PURCELL, RH ;

LEGTERS, LJ .

JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03) :517-521

[4] A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations [J].

Buffet, C ;

LaurentPuig, P ;

Chandot, S ;

Laurian, Y ;

Charpentier, B ;

Briantais, MJ ;

Dussaix, E .

JOURNAL OF HEPATOLOGY, 1996, 24 (01) :122-123

[5]

Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448

[6] Hepatitis E virus [J].

Emerson, SU ;

Purcell, RH .

REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (03) :145-154

[7]

GEROALMI R, 2008, NEW ENGL J MED, P859

[8]

Ibarra H, 1998, CLIN NEPHROL, V50, P267

[9] Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient [J].

Kamar, N ;

Mansuy, JM ;

Esposito, L ;

Legrand-Abravanel, F ;

Peron, JM ;

Durand, D ;

Rostaing, L ;

Izopet, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :193-196

[10] Hepatitis E in pregnancy [J].

Kumar, A ;

Beniwal, M ;

Kar, P ;

Sharma, JB ;

Murthy, NS .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 85 (03) :240-244

← 1 2 3 →